Emageon and Dell Team to Bring Affordable High-end PACS with Advanced Visualization and 3D Capabilities to Small to Mid-sized Hospitals and Clinics

BIRMINGHAM, Ala., June 7 /PRNewswire-FirstCall/ -- Emageon Inc. announced today its new RadSuite Express(TM) solution for the fast growing small to mid-sized hospital and clinic market. With this turn- key solution, facilities producing less than 80,000 radiology studies a year will now be able to install and start using a top-ranked PACS in days. RadSuite Express will give specialists and referring physicians in these smaller facilities access to the same high-end, multi-disciplinary 3D imaging tools used by radiology, orthopedic and emergency specialists in The Johns Hopkins Hospital, the #1 ranked hospital in the United States according to the U.S. News & World Report's annual rankings of "America's Best Hospitals."

Using the expertise gained from its success in the large, enterprise-level Integrated Delivery Network (IDN) market, Emageon is rolling out a simplified Web-enabled, single-server solution based on Dell technology. Emageon chose Dell because of its quality, price leadership, financing options and robust premium support services. Dell's industry-leading e-commerce capability greatly simplifies purchasing and will allow customers to quick- start their PACS operations through Emageon or by ordering the RadSuite Express solution from the www.dell.com Website.

The RadSuite Express product features the imaging best practices, optimized hanging protocols and workflow capability experience that earned Emageon the highest overall vendor rating in the new KLAS(R) April 2007 PACS Perception Report.*

Emageon has achieved an industry leading position by delivering medical image content management, advanced visualization tools and enhanced workflow for large enterprises. More than 500 hospitals and some of the nation's largest hospital operators; including the largest not-for-profit group, Ascension Health; Medical Imaging Magazine's Top Freestanding Imaging Center, Radiological Associates of Sacramento; and major top-rated hospitals in America have all chosen Emageon.

"Emageon's new RadSuite Express offering, built together with Dell, is a great example of combining a world-class software platform with the power of Dell systems to deliver a high quality solution for the health care community," said Dr. James Coffin, Dell's Vice President and General Manager of Health Care and Life Sciences. "This offering strongly supports both companies' vision and commitment to improving patient care through technology."

"We have been analyzing this market segment for some time," said Chuck Jett, Emageon's Chairman, CEO and President. "With RadSuite Express we are now leveraging the knowledge we have gained over seven years to a new market, hungry for the advantages that top-ranked PACS technology can bring -- better tools for physicians, enhanced care for patients and better operating results for hospitals. This simplified solution will be differentiated by a market leading price, long-term content management in remote data centers, on-site service through Dell's proven national support services and purchasing options to fit the customer including traditional capital purchase, lease financing and pure 'pay per study' options."

About Emageon Inc.

Emageon provides enterprise medical information technology systems for hospitals and healthcare networks. Its family of solutions includes RadSuite(TM), HeartSuite(TM), and other specialty suites all built on a unified Enterprise Content Management system offering advanced visualization and infrastructure tools for the clinical analysis and management of all digital medical images, reports and associated clinical content. Emageon's standards-based solutions are designed to help customers enhance patient care, automate imaging workflow, lower costs, improve productivity and provide better service to physicians. For more information, please visit www.emageon.com.

Forward looking Statement

This press release contains forward-looking statements about Emageon which represent the Company's current views with respect to, among other things, future events and financial performance. Any forward-looking statements contained in this press release are based on Emageon's historical performance and on current plans, beliefs and expectations. Actual results may differ materially from those expressed or implied by such forward-looking statements as a result of various risks, uncertainties and other factors beyond its control. These risks, uncertainties and other factors include, among others, the risk that it may not compete successfully against larger competitors, risks associated with its history of operating losses, the risk that it may not manage its growth effectively, risks related to acquisitions, risks associated with its reliance on continuing relationships with large customers, the risk of significant product errors or product failures, its reliance on reseller arrangements for important components of its solution, the risk that it may not respond effectively to changes in its industry, its customers' reliance on third party reimbursements, and the potential impact on its business of FDA regulations and other applicable health care regulations. Additional information concerning these and other factors that could affect Emageon's financial and operating results may be found under the heading "Risk Factors" and elsewhere in the Company's Form 10-K for the year ended December 31, 2006, which was filed with the SEC on March 16, 2007 and latest Form 10-Q which was filed on May 10, 2007. Emageon undertakes no obligation to update these forward-looking statements or any other information provided in this press release except as may be required by law.

*2007 KLAS Enterprises, LLC.

Emageon Inc.

CONTACT: Bill Funderburk of Emageon, +1-205-980-7542,bill.funderburk@emageon.com

Back to news